Neutrophil extracellular trap is an important connection between hemodialysis and acute myocardial infarction

References

• Collaboration GCKD. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:1–11.
   PubMed Web of Science ®Google Scholar
• Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–1982.
   PubMed Web of Science ®Google Scholar
• Saran R, Robinson B, Abbott KC, et al. US renal data system 2019 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2020;75(1):A6–A7.
   PubMedGoogle Scholar
• Siga MM, Ducher M, Florens N, et al. Prediction of all-cause mortality in haemodialysis patients using a Bayesian network. Nephrol Dial Transplant. 2020;35(8):1420–1425.
   PubMed Web of Science ®Google Scholar
• Szummer K, Lindhagen L, Evans M, et al. Treatments and mortality trends in cases with and without dialysis who have an acute myocardial infarction: an 18-Year nationwide experience. Circ Cardiovasc Qual Outcomes. 2019;12(9):e005879.
   PubMed Web of Science ®Google Scholar
• O’Lone E, Viecelli AK, Craig JC, et al. Establishing core cardiovascular outcome measures for trials in hemodialysis: report of an international consensus workshop. Am J Kidney Dis. 2020;76(1):109–120.
   PubMed Web of Science ®Google Scholar
• O’Lone E, Howell M, Viecelli AK, et al. Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals. Nephrol Dial Transplant. 2020;35(10):1761–1769.
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532–1535.
   PubMed Web of Science ®Google Scholar
• Hidalgo A, Libby P, Soehnlein O, et al. Neutrophil extracellular traps: from physiology to pathology. Cardiovasc Res. 2022;118(13):2737–2753.
   PubMed Web of Science ®Google Scholar
• Doring Y, Libby P, Soehnlein O. Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights. Circ Res. 2020;126(9):1228–1241.
   PubMed Web of Science ®Google Scholar
• Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524–533.
   PubMed Web of Science ®Google Scholar
• Laridan E, Martinod K, De Meyer SF. Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost. 2019;45(1):86–93.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Guo L, Dai Q, et al. A signature for pan-cancer prognosis based on neutrophil extracellular traps. J Immunother Cancer. 2022;10(6):e004210.
   PubMed Web of Science ®Google Scholar
• Yan C, Niu Y, Wang X. Blood transcriptome analysis revealed the crosstalk between COVID-19 and HIV. Front Immunol. 2022;13:1008653.
   PubMed Web of Science ®Google Scholar
• Zhang D, Wang M, Zhang Y, et al. Novel insight on marker genes and pathogenic peripheral neutrophil subtypes in acute pancreatitis. Front Immunol. 2022;13:964622.
   PubMed Web of Science ®Google Scholar
• Su W, Zhao Y, Wei Y, et al. Exploring the pathogenesis of psoriasis complicated with atherosclerosis via microarray data analysis. Front Immunol. 2021;12:667690.
   PubMed Web of Science ®Google Scholar
• Jadoul M, Thumma J, Fuller DS, et al. Modifiable practices associated with sudden death among hemodialysis patients in the dialysis outcomes and practice patterns study. Clin J Am Soc Nephrol. 2012;7(5):765–774.
   PubMed Web of Science ®Google Scholar
• Pun PH, Smarz TR, Honeycutt EF, et al. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int. 2009;76(6):652–658.
   PubMed Web of Science ®Google Scholar
• Makar MS, Pun PH. Sudden cardiac death among hemodialysis patients. Am J Kidney Dis. 2017;69(5):684–695.
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Amann K, Bangalore S, et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-Art review. J Am Coll Cardiol. 2019;74(14):1823–1838.
   PubMed Web of Science ®Google Scholar
• do Sameiro-Faria M, Ribeiro S, Costa E, et al. Risk factors for mortality in hemodialysis patients: two-year follow-up study. Dis Markers. 2013;35(6):791–798. 8.[24347
   PubMedGoogle Scholar
• Pereira R, Costa E, Goncalves M, et al. Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure. Hemodial Int. 2010;14(3):295–301.
   PubMed Web of Science ®Google Scholar
• Costa E, Rocha S, Rocha-Pereira P, et al. Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Am J Nephrol. 2008;28(6):935–940.
   PubMed Web of Science ®Google Scholar
• Seropian IM, Toldo S, Van Tassell BW, et al. Anti-inflammatory strategies for ventricular remodeling following ST-segment elevation acute myocardial infarction. J Am Coll Cardiol. 2014;63(16):1593–1603.
   PubMed Web of Science ®Google Scholar
• Naruko T, Ueda M, Haze K, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation. 2002;106(23):2894–2900.
   PubMed Web of Science ®Google Scholar
• Huang S, Sandholm K, Jonsson N, et al. Low concentrations of citrate reduce complement and granulocyte activation in vitro in human blood. Clin Kidney J. 2015;8(1):31–37. 7.
   PubMedGoogle Scholar
• Liakopoulos V, Jeron A, Shah A, et al. Hemodialysis-related changes in phenotypical features of monocytes. Sci Rep. 2018;8(1):13964.
   PubMedGoogle Scholar
• Stavroulopoulos A, Petras D, Kakavas I, et al. Monocyte expression of adhesion molecules during low- and high-flux polysulfone hemodialysis and the effect of atorvastatin administration. Blood Purif. 2010;29(3):274–279.
   PubMed Web of Science ®Google Scholar
• Xie J, Luo C, Mo B, et al. Inflammation and oxidative stress role of S100A12 as a potential diagnostic and therapeutic biomarker in acute myocardial infarction. Oxid Med Cell Longev. 2022;2022:2633123.
   PubMed Web of Science ®Google Scholar
• Korucu B, Yeter H, Gonen S, et al. Impact of medium cut-off membranes on S100A12 and soluble receptor for advanced glycation end products. Semin Dial. 2023;36(3):193–200.
   PubMed Web of Science ®Google Scholar
• Zhang X, Cheng M, Gao N, et al. Corrigendum: utility of S100A12 as an early biomarker in patients with ST-Segment elevation myocardial infarction. Front Cardiovasc Med. 2022;9:840102.
   PubMedGoogle Scholar
• Grauen Larsen H, Yndigegn T, Marinkovic G, et al. The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event. Atherosclerosis. 2019;287:16–23.
   PubMed Web of Science ®Google Scholar
• Shiotsu Y, Mori Y, Nishimura M, et al. Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(4):718–723.
   PubMed Web of Science ®Google Scholar
• Choi BH, Ro H, Jung ES, et al. Circulating S100A12 levels are associated with progression of abdominal aortic calcification in hemodialysis patients. PLoS One. 2016;11(2):e0150145.
   PubMed Web of Science ®Google Scholar
• Shiotsu Y, Mori Y, Nishimura M, et al. Prognostic utility of plasma S100A12 levels to establish a novel scoring system for predicting mortality in maintenance hemodialysis patients: a two-year prospective observational study in Japan. BMC Nephrol. 2013;14:16.
   PubMed Web of Science ®Google Scholar
• Nakashima A, Carrero JJ, Qureshi AR, et al. Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(12):2213–2219.
   PubMed Web of Science ®Google Scholar
• Isoyama N, Leurs P, Qureshi AR, et al. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease stage 5 patients. Nephrol Dial Transplant. 2015;30(1):84–91.
   PubMed Web of Science ®Google Scholar
• Yan W, Song H, Jiang J, et al. Characteristics of B cell associated gene expression in patients with coronary artery disease. Mol Med Rep. 2016;13(5):4113–4121.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang X, Duan M, et al. Identification of potential biomarkers associated with acute myocardial infarction by weighted gene coexpression network analysis. Oxid Med Cell Longev. 2021;2021:5553811.
   PubMed Web of Science ®Google Scholar
• Wu Y, Jiang T, Hua J, et al. Integrated Bioinformatics-Based analysis of hub genes and the mechanism of immune infiltration associated with acute myocardial infarction. Front Cardiovasc Med. 2022;9:831605.
   PubMed Web of Science ®Google Scholar
• Heymes C, Bendall JK, Ratajczak P, et al. Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol. 2003;41(12):2164–2171.
   PubMed Web of Science ®Google Scholar
• Krijnen PA, Meischl C, Hack CE, et al. Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol. 2003;56(3):194–199.
   PubMed Web of Science ®Google Scholar
• Grieve DJ, Byrne JA, Siva A, et al. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload. J Am Coll Cardiol. 2006;47(4):817–826.
   PubMed Web of Science ®Google Scholar
• Looi YH, Grieve DJ, Siva A, et al. Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension. 2008;51(2):319–325.
   PubMed Web of Science ®Google Scholar
• Lim SY, Hausenloy DJ, Arjun S, et al. Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure. J Cell Mol Med. 2011;15(11):2443–2451.
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108(17):2154–2169.
   PubMed Web of Science ®Google Scholar
• Workgroup KD. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(3):S1–S153.
   Google Scholar
• Granata S, Zaza G, Simone S, et al. Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics. 2009;10:388.
   PubMed Web of Science ®Google Scholar